AKSHARCHEM:NSE-AksharChem (India) Limited (INR)

COMMON STOCK | Specialty Chemicals | NSE

Last Closing Price

INR 148.80

Change

+4.00 (+2.76)%

Market Cap

INR 1.25B

Volume

4.64K

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

AksharChem (India) Limited manufactures and sells dyes and pigments in India. It offers vinyl sulphone and H-acid for use in the textile industry; and CPC Green, a raw material used in the printing ink, paint, rubber, plastic, and leather industries. It also exports its products to Europe, the Far East, South East Asia, China, the United States, and internationally. The company was formerly known as Audichem (India) Limited and changed its name to AksharChem (India) Limited in March 2003. AksharChem (India) Limited was founded in 1989 and is headquartered in Mehsana, India.

Employees : 137

Currency: INR

Country : India

Technical Indicators

Beta : 0.32

52 Week High : 375.00

52 Week Low : 134.00

200 Day Moving Average : 221.33

50 Day Moving Average : 241.03

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-03-27 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ASIANPAINT:NSE Asian Paints Limited

-12.80 (-0.79%)

 INR1,532.22B 56.30 39.88
BERGEPAINT:NSE Berger Paints India Limited

+7.30 (+1.53%)

 INR390.97B 58.67 37.27
KANSAINER:NSE Kansai Nerolac Paints Limited

+12.65 (+3.67%)

 INR196.04B 36.62 24.30
AARTIIND:NSE Aarti Industries Limited

+27.25 (+3.69%)

 INR131.55B 32.75 14.67
ATUL:NSE Atul Ltd

+21.55 (+0.54%)

 INR116.57B 18.31 12.47
CASTROLIND:NSE Castrol India Limited

-6.15 (-5.86%)

 INR100.79B 12.20 8.20
AKZOINDIA:NSE Akzo Nobel India Limited

+70.15 (+3.43%)

 INR91.54B 36.08 23.29
FINEORG:NSE Fine Organic Industries Limite..

+44.30 (+2.32%)

 INR60.09B 38.25 25.21
LINDEINDIA:NSE Linde India Limited

+7.90 (+1.65%)

 INR36.72B 5.01 8.20
DCMSHRIRAM:NSE DCM Shriram Limited

+0.80 (+0.39%)

 INR32.23B 3.99 3.14

ETFs Containing AKSHARCHEM

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -41.06% 39% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.06% 39% F 41% F
Trailing 12 Months  
Capital Gain -55.90% 34% F 44% F
Dividend Return 1.04% 61% D- 56% F
Total Return -54.86% 34% F 45% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -27.80% 4% F 8% F
Dividend Return 0.14% 5% F 7% F
Total Return -27.66% 4% F 8% F
Risk Return Profile  
Volatility (Standard Deviation) 22.18% 80% B- 82% B-
Risk Adjusted Return -124.70% 4% F 4% F
Market Capitalization 1.25B 32% F 37% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.95 46% F 50% F
Price/Book Ratio 0.46 76% C 62% D-
Price / Cash Flow Ratio -14.19 93% A 94% A
EV/EBITDA 5.73 52% F 48% F
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 7.34% 25% F 43% F
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.32 51% F 59% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector